[ad_1]
SYNICEM spacers are designed to assist orthopaedic surgeons in the revision of hip, knee, and shoulder surgeries. Unlike traditional intra-operative moulded and handmade spacers, these antibiotic-loaded, preformed spacers address the challenges of maintaining articular space and aiding the treatment of infection. They are precision-engineered for consistency and structural uniformity, offering high local concentrations of gentamicin and saving surgeons’ time during procedures with their ready-to-use format and case-by-case flexibility.
Rohit Dhawan, a consultant orthopaedic surgeon, praises the practicality and versatility of SYNICEM spacers, emphasizing their readiness for use and suitability for various patient anatomies, leading to efficient procedures and infection-free outcomes for patients.
Michael Harris, CEO of Biocomposites, expressed enthusiasm about the addition of SYNICEM spacers to their product lineup. He highlighted the strategic acquisition of Synimed as a move that enriches their portfolio and supports surgeons in managing and treating infections. The introduction of SYNICEM spacers in the UK and into the broader Biocomposites network is a significant step in ensuring more patients benefit from these advanced medical solutions.
[ad_2]
http://www.trendhunter.com/trends/synicemtm